Get Higher Crop Yields with Agribody Technologies


Agribody Technologies, Inc. seeks to license and co-develop patented crop yield-enhancing technology. ATI leads the crop development revolution with a unique crop genetic technology, shown to increase crop yield, improve stress tolerance, disease resistance, and product shelf life. ATI strives to increase the market share and profit margins of our partner seed companies by providing our patented and validated technology, resulting in improved crops for farmers, more efficient use of scarce resources, and lower prices with better products for consumers.


Our Story

Agribody Technologies was founded in August 2015 by Jerry Feitelson, Ph.D. and Professor John Thompson, Ph.D. based on intellectual property developed in John's lab at the University of Waterloo, Canada.  Our team is committed to improving plant yields, tolerance to abiotic stress and disease, and product shelf life through genetic engineering or genome editing of crops such as corn, soy, alfalfa, cotton, sugarbeet, canola, potato, peanut, beans, rice, sorghum and others.


To meet a growing demand for high-quality, low-cost food, farmers and their seed company suppliers must substantially increase food production and storage efficiency under normal and stressed conditions. Through genetic engineering or genome editing of many crop plants with our patent protected genetic plant technology, our IP covers a key genetic switch with broad applications in multiple plant species. Farmers can grow a wider variety of crops, experience significantly higher yields and stress tolerance, while using the same inputs, reducing risks and increasing profits.


Agribody technology has been validated in both lab and greenhouse studies for multiple crops.  Most importantly, during two years of replicated field trials, yield improvements of 20-45% were demonstrated in an elite alfalfa variety with little to no loss of quality.

Our Team

The Agribody Technologies Team: Our technically diverse, entrepreneurial and highly efficient team has extensive directly relevant experience in their respective specialty areas.

Executive Team

Jerry Feitelson, Ph.D. - CEO / Co-Founder

  • 30 years industrial R&D, IP, Licensing, Bus Dev & entrepreneurial experience

  • Managed $10 Mil/year royalty revenues; Negotiated $7 Mil license

  • Patented B.t. genes/proteins partially leading to ~$850 Mil IP valuation at Mycogen

  • Co-founder/early employee at 3 ag biotech companies

  • B.S. (MIT), Ph.D (Stanford), NIH Postdoc (John Innes Institute, UK)

John Thompson, Ph.D. - Chief Scientist / Co-Founder

  • University of Waterloo (Emeritus Professor, Associate VP Research)

  • Invented eIF5A/DHS technology

  • Extensively published, cited and patented

  • B.S. (Toronto), Ph.D. (Alberta), Fellow of Royal Society of Canada

Venki Pegadaraju, Ph.D. - VP Business Development

  • >16 years R&D, Bus & Market Dev, Sales

  • Managed Agrigenomics Business Development at Illumina (>$200 Mil rev)

  • Managed $6 Mil public-private fund (Gates Foundation)

  • Ph.D. (Kansas State)

Paul Kreutz - Counsel

  • Practiced law in SF Bay Area from 1967-1994; built Gray Cary’s office in San Diego

  • Represented many VC firms:  Enterprise Partners, Forward Ventures, etc.

  • Counsels & helps structure growth-oriented entrepreneurial enterprises

  • B.A. (Yale), LL.B. (Stanford)

Jim Goode - Acting CFO

  • 35 years managing financial/admin functions of small-medium growth companies

  • Raised >$100 Mil for clients, acquisitions, global business & turnarounds

  • Provided part-time CFO services for >20 years in high-tech, biotech and start-ups

  • MBA valedictorian (UCLA), CPA (Arthur Young)


Alan Bennett, Ph.D. - Chair SAB

  • UC-Davis (Professor of Plant Science)

  • Transformed/characterized elite alfalfa with eIF5A

  • Runs advanced genetics lab

  • Extensively published, cited and patented

  • B.S. (UC-Davis), Ph.D. (Cornell)

Craig Williams - Field Trials / Regulatory

  • 25 years experience managing seed companies

  • Knowledgeable in seed business operations, regulatory affairs, field trials, M&A due diligence

  • B.S. (Bradley U.)

Dereck Tatman, Ph.D., MBA - Advisor

  • Senior Business Development and Operations Executive

  • Spent 16 years at Sequenom

  • Led several multi-$100s Million deals

  • B.A. (Wabash College), Ph.D. (AZ State), MBA (Purdue U.)

Vaughn Smider, M.D., Ph.D. - Advisor

  • CSO of Sevion Therapeutics, Founder/President of its precursor company, Fabrus.

  • Associate Professor at The Scripps Research Institute in protein engineering

  • Leadership Council for American Cancer Society

  • B.A (Hiram College), M.D. & Ph.D. (Stanford U.)


Agribody Technologies, Inc.

12526 High Bluff Dr. #300

San Diego, CA 92130

© 2021 by Agribody Technologies, Inc.